Ally Bridge
Ally Bridge backs Chinese oncology-focused big data company
Healthcare-focused GP Ally Bridge Group has led a Series B round of funding for LinkDoc Technology, an oncology-focused big data company based in China.
Corporate VC in China healthcare: Formula for success
Despite the rapid growth of the Chinese pharmaceutical industry, corporate venture capital so far has not built a large presence. Industry participants say this shows the market, though booming, is still immature
China take-privates: New wave
Recent volatility notwithstanding, plenty of investors want to back China take-privates with a view to domestic re-listings at higher valuations. The company founders behind these deals are the big winners
PE consortium completes take-private of China's WuXi PharmaTech
A consortium comprising the founder and CEO of WuXi PharmaTech and several PE investors has completed the privatization of the China-based provider of contract R&D services to global pharmaceutical companies.
WuXi Pharmatech wins endorsement for PE-backed take-private
The proposed privatization of WuXi PharmaTech, a China-based provider of contract R&D services to the global pharmaceutical sector, has won the support of two major shareholder proxy advisory firms.
Chinese personal finance app Wacai secures additional $80m
Hangzhou Wacai Science, a Chinese personal finance management mobile app developer, has raised an additional $80 million in an extended Series B round of funding led by New Horizon Capital.
China healthcare: The specialists
On the back of reforms and a rising consumer class, China's healthcare sector is expected to see huge growth. Sector specialists have emerged to capitalize on the opportunity. How can they differentiate themselves?
Ally Bridge supports WuXi PharmaTech take-private
WuXi PharmaTech, a China-based provider of contract R&D services to the global pharmaceutical sector, has received a take-private bid led by its founder and chairman and healthcare-focused PE firm Ally Bridge Group.
Ally Bridge participates in $57m round for US biotech firm
Healthcare-focused GP Ally Bridge has participated in a $57 million round of funding for EndoChoice, a US-based endoscopic imaging specialist, with a view to helping the company to expand in China.